Early Prediction of Outcomes Following Optic Neuritis: Development and Acceptability of a Prognostic Tool
NCT07704294 · Status: NOT_YET_RECRUITING · Type: OBSERVATIONAL · Enrollment: 180
Last updated 2026-07-15
Summary
The goal of this observational study is to determine whether genetic information, together with clinical information, can be used to improve prediction of future multiple sclerosis (MS) diagnosis after a first-time episode of optic neuritis. The study will also investigate visual outcomes, quality of life, healthcare use, and the acceptability of using genetic information to predict future health outcomes in people with optic neuritis.
The main outcomes that we aim to assess are:
1. Incident diagnosis of MS following a first episode of optic neuritis, including time to MS diagnosis.
2. Visual outcomes following optic neuritis, including visual acuity, visual field, and colour vision.
3. Clinical care received following optic neuritis, including specialist review, investigations/tests
4. Health-related and vision-related quality of life.
5. Health economic impacts and healthcare utilisation after experiencing optic neuritis
6. Knowledge, attitudes, and practices/behaviours about using genetic information to predict future MS disease risk.
If consented, participants will:
1. Allow researchers to review information from their medical records relating to their optic neuritis diagnosis, investigations, treatments, and outcomes.
2. Be invited to provide a saliva sample for genetic analysis.
3. Complete questionnaires about their lifestyle/risk factors, quality of life, and views on genetic risk prediction.
4. Allow researchers to track long-term health outcomes using information from their NHS records
Conditions
- Optic Neuritis
- Multiple Sclerosis
- Neuromyelitis Optica Spectrum Disorder
- Myelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders
- Sarcoid
Interventions
- OTHER
-
No Intervention: Observational Cohort
Not applicable - No intervention as this is an observation study
Sponsors & Collaborators
-
Guy's and St Thomas' NHS Foundation Trust
collaborator OTHER -
King's College Hospital NHS Trust
collaborator OTHER -
Moorfields Eye Hospital NHS Foundation Trust
collaborator OTHER - lead OTHER
Principal Investigators
-
Tasanee Braithwaite · King's College London
Eligibility
- Min Age
- 16 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2026-09-01
- Primary Completion
- 2027-12-01
- Completion
- 2027-12-01
Countries
- United Kingdom
Study Locations
More Related Trials
-
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis (Switzerland)
NCT06526364 ·Status: RECRUITING
-
Use of a Smartphone Application to Predict the Prognosis in Patients With Newly Diagnosed Multiple Sclerosis.
NCT04595799 ·Status: ACTIVE_NOT_RECRUITING
-
Multiple Sclerosis Prediction and Monitoring of Progression Study
NCT05685784 ·Status: RECRUITING ·Phase: NA
-
Patient Research Cohort: Rapidly Evolving Multiple Sclerosis
NCT01044576 ·Status: COMPLETED
-
Combined Analysis of Inflammatory Biomarkers for CNS Autoimmune Diseases Diagnostic
NCT05056740 ·Status: RECRUITING
-
Atacicept in Subjects With Optic Neuritis
NCT00624468 ·Status: TERMINATED ·Phase: PHASE2
-
Expression of PARP-1 in Multiple Sclerosis Patients
NCT05196425 ·Status: COMPLETED ·Phase: NA
-
From Genetics to Transcriptomics to Unravel the Mechanisms Behind a Poor Outcome in Multiple Sclerosis
NCT04873492 ·Status: RECRUITING ·Phase: NA
-
Multimodal Exploration of Patients With Multiple Sclerosis for an Early Detection of Subtle Progression
NCT05941975 ·Status: RECRUITING ·Phase: NA
-
CorEvitas SPHERES (Synergy of Prospective Health & Experimental Research for Emerging Solutions) Registry for Neuromyelitis Optica Spectrum Disorder (NMOSD)
NCT04886492 ·Status: ENROLLING_BY_INVITATION
-
An Observational Biomarker Study in Multiple Sclerosis (MS) Patients
NCT05663853 ·Status: COMPLETED
-
Serum Neurofilament Light in Multiple Sclerosis
NCT06282081 ·Status: ACTIVE_NOT_RECRUITING
-
Clinnova-MS: A Prospective Cohort Study of Patients With Multiple Sclerosis: A Trans-regional Digital Health Effort Unlocking the Potential of Artificial Intelligence and Data Science in Health Care
NCT07280871 ·Status: NOT_YET_RECRUITING
-
[18F]PBR111 and Microglial Activation in Multiple Sclerosis
NCT01428505 ·Status: TERMINATED ·Phase: PHASE2
-
Evaluating Multiple Sclerosis Patients ShOWing A GEnomic Signature of Therapy Response
NCT03316404 ·Status: COMPLETED
-
Identification of Retinal Perivascular Inflammation in Patients With Multiple Sclerosis Using Adaptive Optics (RETIMUS)
NCT04289909 ·Status: COMPLETED ·Phase: NA
-
Risk Factors in Early Multiple Sclerosis
NCT03586986 ·Status: UNKNOWN
-
Efficacy and Safety of Monoclonal Antibody in Acute Phase of Neuromyelitis Optica Spectrum Disorder
NCT07182409 ·Status: NOT_YET_RECRUITING
-
Measuring Active Microglia in Progressive Multiple Sclerosis
NCT02207075 ·Status: COMPLETED
-
Predicting Disease Activity and Rebound Risk in MS Patients Treated With Sphingosine-1-phosphate Receptor Modulators (S1PRM)
NCT05828901 ·Status: TERMINATED
-
Effect of Ocrelizumab on Neuroinflammation in Multiple Sclerosis as Measured by 11C-PBR28 MR-PET Imaging of Microglia Activation
NCT04230174 ·Status: COMPLETED ·Phase: PHASE4
-
A Prospective Longitudinal Study in Adults With Multifocal Motor Neuropathy
NCT05988073 ·Status: ACTIVE_NOT_RECRUITING
-
Neuroprotection and Repair in Optic Neuritis
NCT01073813 ·Status: TERMINATED ·Phase: PHASE2
-
Prospective Investigation of Multiple Sclerosis in the Three Rivers Region
NCT02994121 ·Status: RECRUITING
-
Next-Gen MS: Feed-forward PRO Data for MS Research
NCT04907305 ·Status: TERMINATED